GCT Authorized Value Terminology

Preferred Label : GCT Authorized Value Terminology;

NCIt synonyms : Germ Celll Tumor Authorized Value Terminology;

NCIt definition : Terms that have been designated as being a authorized value within the PCDC Terminology and GCT project.;

NCI Metathesaurus CUI : CL1643334;

Détails

Origin ID

C177383;

UMLS CUI

C5783398;

Semantic type(s)
- Intellectual Product [UMLS semantic type]
concept_is_in_subset
- PCDC Terminology [NCIt concept]
subset_includes_concept
- 45,XO Karyotype [NCIt concept]
- 45,XO with Y Chromosomal Material [NCIt concept]
- 47,XXX Karyotype [NCIt concept]
- 47,XXY Karyotype [NCIt concept]
- 47,XYY Karyotype [NCIt concept]
- 48,XXXX Karyotype [NCIt concept]
- 48,XXXY Karyotype [NCIt concept]
- AGCT0132 GCT Study Identifier [NCIt concept]
- AGCT01P1 GCT Study Identifier [NCIt concept]
- AGCT0521 GCT Study Identifier [NCIt concept]
- AYA-HEARS [NCIt concept]
- Abnormal Karyotype [NCIt concept]
- Absent [NCIt concept]
- Absolute [NCIt concept]
- Adenocarcinoma [NCIt concept]
- Adverse Event Contributory to Cause of Death [NCIt concept]
- Adverse Event Definitely Related to Intervention [NCIt concept]
- Adverse Event Possibly Related to Intervention [NCIt concept]
- Adverse Event Probably Related to Intervention [NCIt concept]
- Adverse Event Unlikely Related to Intervention [NCIt concept]
- Adverse Event Unrelated to Intervention [NCIt concept]
- Alive [NCIt concept]
- Alpha-fetoprotein Measurement [NCIt concept]
- American Indian or Alaska Native [NCIt concept]
- American Joint Committee on Cancer [NCIt concept]
- Amifostine [NCIt concept]
- Ascites Fluid Sample [NCIt concept]
- Asian [NCIt concept]
- Bilateral [NCIt concept]
- Biopsy Procedure [NCIt concept]
- Black or African American [NCIt concept]
- Bleomycin [NCIt concept]
- Blood Sample [NCIt concept]
- Body Height [NCIt concept]
- Body Weight [NCIt concept]
- Bone [NCIt concept]
- Brain [NCIt concept]
- Brazilian Society of Pediatric Oncology [NCIt concept]
- CSF Analysis [NCIt concept]
- Carboplatin [NCIt concept]
- Catenin Beta-1 [NCIt concept]
- Centimeter [NCIt concept]
- Central Nervous System Germinoma [NCIt concept]
- Cerebrospinal Fluid [NCIt concept]
- Cerebrospinal Fluid Sample [NCIt concept]
- Cervix Uteri [NCIt concept]
- Chemotherapy [NCIt concept]
- Children's Cancer and Leukaemia Group [NCIt concept]
- Children's Oncology Group [NCIt concept]
- Choi Response Criteria in the Evaluation of Gastrointestinal Stromal Tumors [NCIt concept]
- Choriocarcinoma [NCIt concept]
- Choriogonadotropin Beta Measurement [NCIt concept]
- Chromosomal Translocation [NCIt concept]
- Cisplatin [NCIt concept]
- Complete Remission [NCIt concept]
- Complete Resection [NCIt concept]
- Copy Number Polymorphism [NCIt concept]
- Cyclophosphamide [NCIt concept]
- Cytogenetics [NCIt concept]
- Cytology [NCIt concept]
- DNA Sequence Rearrangement [NCIt concept]
- Dactinomycin [NCIt concept]
- Dana Farber Cancer Institute [NCIt concept]
- Dead [NCIt concept]
- Death Related to Adverse Event [NCIt concept]
- Death due to Disease Progression [NCIt concept]
- Death, Adverse Event is Noncontributory [NCIt concept]
- Deletion Mutation [NCIt concept]
- Droplet Digital PCR [NCIt concept]
- Embryonal Carcinoma [NCIt concept]
- Etoposide [NCIt concept]
- Etoposide Phosphate [NCIt concept]
- FACT Ntx Questionnaire [NCIt concept]
- FIGO Stage I [NCIt concept]
- FIGO Stage II [NCIt concept]
- FIGO Stage III [NCIt concept]
- FIGO Stage IV [NCIt concept]
- Federation of Gynecology and Obstetrics [NCIt concept]
- Female [NCIt concept]
- Frasier Syndrome [NCIt concept]
- Frontal Lobe Cortex [NCIt concept]
- GC1 GCT Study Identifier [NCIt concept]
- GC2 GCT Study Identifier [NCIt concept]
- GOG0078 GCT Study Identifier [NCIt concept]
- GOG0090 GCT Study Identifier [NCIt concept]
- GOG0116 GCT Study Identifier [NCIt concept]
- Gemcitabine [NCIt concept]
- Germinomatous Germ Cell Tumor [NCIt concept]
- Glypican-3 [NCIt concept]
- Gonadoblastoma [NCIt concept]
- Grade 1 [NCIt concept]
- Grade 2 [NCIt concept]
- Grade 3 [NCIt concept]
- Gray [NCIt concept]
- Gross Total Resection [NCIt concept]
- Head and Neck [NCIt concept]
- Hispanic or Latino [NCIt concept]
- Ifosfamide [NCIt concept]
- Imaging Procedure [NCIt concept]
- Immature Teratoma [NCIt concept]
- Initial Diagnosis [NCIt concept]
- Institution [NCIt concept]
- International Unit [NCIt concept]
- International Unit per Liter [NCIt concept]
- Inversion Mutation Abnormality [NCIt concept]
- Italian Association of Pediatric Hematology and Oncology [NCIt concept]
- Karyotyping [NCIt concept]
- Kilogram [NCIt concept]
- Klinefelter Syndrome [NCIt concept]
- Lactate Dehydrogenase Measurement [NCIt concept]
- Left [NCIt concept]
- Life Threatening or Disabling Adverse Event [NCIt concept]
- Liver [NCIt concept]
- Lung [NCIt concept]
- Male [NCIt concept]
- Malignant Germ Cell International Collaborative Risk Classification, Low [NCIt concept]
- Malignant Germ Cell International Collaborative Risk Classification, Poor [NCIt concept]
- Malignant Germ Cell International Collaborative Risk Classification, Standard [NCIt concept]
- Malignant Histiocytosis [NCIt concept]
- Malignant Teratoma [NCIt concept]
- Mature Teratoma [NCIt concept]
- Mediastinum [NCIt concept]
- Medical Research Council [NCIt concept]
- Melphalan [NCIt concept]
- Metastatic Neoplasm [NCIt concept]
- MicroRNA 367-3p Measurement [NCIt concept]
- MicroRNA 371a-3p Measurement [NCIt concept]
- MicroRNA 372-3p Measurement [NCIt concept]
- MicroRNA 373-3p Measurement [NCIt concept]
- MicroRNA 375-3p Measurement [NCIt concept]
- MicroRNA Sequencing [NCIt concept]
- Microgram per Liter [NCIt concept]
- Midline [NCIt concept]
- Mild Adverse Event [NCIt concept]
- Milligram [NCIt concept]
- Milligram per Kilogram [NCIt concept]
- Milligram per Square Meter [NCIt concept]
- Mixed Germ Cell Tumor [NCIt concept]
- Moderate Adverse Event [NCIt concept]
- Modified RECIST Byrne Mesothelioma 2004 Oncology Response Criteria [NCIt concept]
- Multi-Institutional Clinical Trial [NCIt concept]
- Multiracial [NCIt concept]
- Mutation Abnormality [NCIt concept]
- NRG-Oncology [NCIt concept]
- Native Hawaiian or Other Pacific Islander [NCIt concept]
- Neuropathy [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Good [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Intermediate [NCIt concept]
- Non-Seminomatous Germ Cell Tumor International Consensus Risk Classification, Poor [NCIt concept]
- Normal Karyotype [NCIt concept]
- Not Hispanic or Latino [NCIt concept]
- Not Recovered from Adverse Event [NCIt concept]
- Not Reported [NCIt concept]
- Occipital Lobe Cortex [NCIt concept]
- Omentum [NCIt concept]
- Other [NCIt concept]
- Ototoxicity [NCIt concept]
- Ovarian Dysgerminoma [NCIt concept]
- Ovary [NCIt concept]
- Overall Response [NCIt concept]
- P9749 GCT Study Identifier [NCIt concept]
- PET Response Criteria in Solid Tumors [NCIt concept]
- POG9049 GCT Study Identifier [NCIt concept]
- Paclitaxel [NCIt concept]
- Parietal Lobe Cortex [NCIt concept]
- Partial Remission [NCIt concept]
- Partial Resection [NCIt concept]
- Pathology [NCIt concept]
- Pediatric Quality of Life Inventory-Multidimensional Fatigue Scale [NCIt concept]
- PedsQL 4.0 Generic Core Scale [NCIt concept]
- Pelvis [NCIt concept]
- Percent Unit [NCIt concept]
- Peritoneal Fluid Sample [NCIt concept]
- Peritoneum [NCIt concept]
- Photon [NCIt concept]
- Pineal Gland [NCIt concept]
- Plasma Sample [NCIt concept]
- Positron Emission Tomography [NCIt concept]
- Present [NCIt concept]
- Primary Neoplasm [NCIt concept]
- Primitive Neuroectodermal Tumor [NCIt concept]
- Progressive Disease [NCIt concept]
- Proton Beam Radiation Therapy [NCIt concept]
- Pulmonary Toxicity [NCIt concept]
- Real Time PCR [NCIt concept]
- Recovered from Adverse Event [NCIt concept]
- Recovered from Adverse Event with Sequelae [NCIt concept]
- Recurrent Disease [NCIt concept]
- Relative Value [NCIt concept]
- Renal Toxicity [NCIt concept]
- Response Evaluation Criteria in Solid Tumors [NCIt concept]
- Retroperitoneum [NCIt concept]
- Rhabdomyosarcoma [NCIt concept]
- Right [NCIt concept]
- Sacrococcygeal Joint [NCIt concept]
- Sarcoma [NCIt concept]
- Secondary Malignant Neoplasm [NCIt concept]
- Seminoma [NCIt concept]
- Serum Sample [NCIt concept]
- Severe Adverse Event [NCIt concept]
- Single Nucleotide Variant [NCIt concept]
- Societe Francaise de Lutte contre les Cancers et Leucemies de l'Enfant et de l'Adolescent [NCIt concept]
- Sodium Thiosulfate [NCIt concept]
- Spinal Cord [NCIt concept]
- Squamous Cell Carcinoma [NCIt concept]
- Stable Disease [NCIt concept]
- Stage 0 Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage I [NCIt concept]
- Stage I Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage II [NCIt concept]
- Stage II Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIC Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage III [NCIt concept]
- Stage III Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIA Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIB Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IIIC Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IS Testicular Cancer AJCC v6 and v7 [NCIt concept]
- Stage IV [NCIt concept]
- Suprasellar/Neurohypophyseal [NCIt concept]
- Surgical Procedure [NCIt concept]
- Swyer James Syndrome [NCIt concept]
- TCGM2004 Germ Cell Tumor Study Identifier [NCIt concept]
- TE04 GCT Study Identifier [NCIt concept]
- TE05 GCT Study Identifier [NCIt concept]
- TE08 GCT Study Identifier [NCIt concept]
- TE09 GCT Study Identifier [NCIt concept]
- TE13 GCT Study Identifier [NCIt concept]
- TE20 GCT Study Identifier [NCIt concept]
- TE22 GCT Study Identifier [NCIt concept]
- TGM85 GCT Study Identifier [NCIt concept]
- TGM90 GCT Study Identifier [NCIt concept]
- TGM95 GCT Study Identifier [NCIt concept]
- TIP GCT Study Identifier [NCIt concept]
- Temporal Lobe Cortex [NCIt concept]
- Teratoma [NCIt concept]
- Teratoma with Somatic-Type Malignancy [NCIt concept]
- Testis [NCIt concept]
- Thalamus [NCIt concept]
- Treatment-Related Mortality [NCIt concept]
- Tumor Cell Necrosis [NCIt concept]
- Tumor Marker [NCIt concept]
- Tumor Necrosis Factor Receptor Superfamily Member 8 [NCIt concept]
- Turner Syndrome [NCIt concept]
- Undifferentiated Sex [NCIt concept]
- Unit per Liter [NCIt concept]
- Unknown [NCIt concept]
- Vagina [NCIt concept]
- Vertebral Column [NCIt concept]
- Vinblastine [NCIt concept]
- Vincristine [NCIt concept]
- White [NCIt concept]
- World Health Organization [NCIt concept]
- XX Genotype [NCIt concept]
- XY Genotype [NCIt concept]
- Yes [NCIt concept]
- Yolk Sac Tumor [NCIt concept]
- cfDNA or ctDNA Measurement [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients